166 related articles for article (PubMed ID: 30150457)
1. Catheter-related Complications of Subcutaneous Implantable Venous Access Devices in Breast Cancer Patients.
El-Balat A; Schmeil I; Karn T; Holtrich U; Mavrova-Risteska L; Rody A; Youssef A; Hanker LC
In Vivo; 2018; 32(5):1275-1281. PubMed ID: 30150457
[TBL] [Abstract][Full Text] [Related]
2. Is there any effect of first-day usage of a totally implantable venous access device on complications?
Karanlik H; Odabas H; Yildirim I; Ozgur I; Kilic B; Sen F; Kurul S; Aydiner A
Int J Clin Oncol; 2015 Dec; 20(6):1057-62. PubMed ID: 25911604
[TBL] [Abstract][Full Text] [Related]
3. Radio-opacity and incidental identified mechanical complications of totally implantable venous access devices placed in the chest.
Surov A; Rusner C; Weigand K; John E; Spielmann RP; Behrmann C
Acta Radiol; 2012 Nov; 53(9):1035-9. PubMed ID: 23028172
[TBL] [Abstract][Full Text] [Related]
4. Right or left? Side selection for a totally implantable vascular access device: a randomised observational study.
Lin WY; Lin CP; Hsu CH; Lee YH; Lin YT; Hsu MC; Shao YY
Br J Cancer; 2017 Sep; 117(7):932-937. PubMed ID: 28787431
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of catheter-related thrombosis in early-stage breast cancer patients: a single-center retrospective study.
Tan L; Sun Y; Zhu L; Lei X; Liang D; Rao N; Su F; Chen K; Li S
Cancer Manag Res; 2019; 11():8379-8389. PubMed ID: 31571994
[TBL] [Abstract][Full Text] [Related]
6. Clinical review and analysis of complications of totally implantable venous access devices for chemotherapy.
Kim JT; Oh TY; Chang WH; Jeong YK
Med Oncol; 2012 Jun; 29(2):1361-4. PubMed ID: 21380779
[TBL] [Abstract][Full Text] [Related]
7. Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage.
Singh KR; Agarwal G; Nanda G; Chand G; Mishra A; Agarwal A; Verma AK; Mishra SK; Goyal P
World J Surg; 2014 May; 38(5):1084-92. PubMed ID: 24305930
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the position of the central venous catheter tip of implantable venous access devices in the occurrence of postoperative thrombotic and non-thrombotic complications.
Hamri H; Pop CF; Mauriac S; Degreve C; Khaled C; Vouche M; Moreau M; Liberale G
Support Care Cancer; 2024 May; 32(6):355. PubMed ID: 38750256
[TBL] [Abstract][Full Text] [Related]
9. Which is Better for Patients with Breast Cancer: Totally Implanted Vascular Access Devices (TIVAD) or Peripherally Inserted Central Catheter (PICC)?
Tang TT; Liu L; Li CX; Li YT; Zhou T; Li HP; Wang J
World J Surg; 2019 Sep; 43(9):2245-2249. PubMed ID: 31098669
[TBL] [Abstract][Full Text] [Related]
10. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placement.
Liberale G; El Houkayem M; Viste C; Bouazza F; Moreau M; El Nakadi I; Veys I
Support Care Cancer; 2016 Dec; 24(12):5035-5040. PubMed ID: 27495928
[TBL] [Abstract][Full Text] [Related]
12. Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems.
Hartkamp A; van Boxtel AJ; Zonnenberg BA; Witteveen PO
Neth J Med; 2000 Dec; 57(6):215-23. PubMed ID: 11099790
[TBL] [Abstract][Full Text] [Related]
13. Totally implanted venous access devices implanted in the saphenous vein. Relation between the reservoir site and comfort/discomfort of the patients.
Toro A; Mannino M; Cappello G; Celeste S; Cordio S; Di Carlo I
Ann Vasc Surg; 2012 Nov; 26(8):1127.e9-1127.e13. PubMed ID: 22951064
[TBL] [Abstract][Full Text] [Related]
14. [Complications with totally implantable venous access device. A retrospective of 116 cases].
Talfer S; Conessa C; Hervé S; Roguet E; de Rotalier P; Poncet JL
Presse Med; 2003 Aug; 32(27):1263-8. PubMed ID: 14506448
[TBL] [Abstract][Full Text] [Related]
15. Comparison of complications between peripheral arm ports and central chest ports: A meta-analysis.
Wu S; Li W; Zhang Q; Li S; Wang L
J Adv Nurs; 2018 Nov; 74(11):2484-2496. PubMed ID: 29917252
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound-guided totally implantable venous access device through the right innominate vein in older patients is safe and reliable.
Sun X; Zhang Y; Yang C; Zhou Y; Bai X; Zheng W; Jin Y
Geriatr Gerontol Int; 2019 Mar; 19(3):218-221. PubMed ID: 30724007
[TBL] [Abstract][Full Text] [Related]
17. Assessing the time-to-removal of totally implantable venous access devices comparing valved-versus open-ended catheters in patients treated with chemotherapy.
Amroun K; Brugel M; Rhaiem R; Teuma L; Vannieuwenhuyse G; Lipere A; Brenet E; Kianmanesh R; Bouché O
J Vasc Access; 2024 Jan; ():11297298231223539. PubMed ID: 38205615
[TBL] [Abstract][Full Text] [Related]
18. Availability of totally implantable venous access devices in cancer patients is high in the long term: a seven-year follow-up study.
Tumay LV; Guner OS
Support Care Cancer; 2021 Jul; 29(7):3531-3538. PubMed ID: 33155092
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of totally implantable venous access devices.
Wang YC; Lin PL; Chou WH; Lin CP; Huang CH
Support Care Cancer; 2017 Jul; 25(7):2049-2054. PubMed ID: 28181014
[TBL] [Abstract][Full Text] [Related]
20. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
